Dr. Zgheib is an innovative and highly driven clinical/scientific expert driven by a passion for biomedical innovation, focused on unmet medical needs with the goal of improving human health. Dr. Zgheib has an expansive background in leadership and over 16 years of experience in biomedical research. He has extensive experience in regenerative medicine, tissue repair, nanotechnology, and biomaterials. Dr. Zgheib is the chief scientific officer of Ceria Therapeutics, inc., a biotechnology company focused on developing innovative and novel therapies to treat overactive and nonproductive inflammation to promote healing. He is also a faculty at the Department of Surgery at the University of Colorado Denver - Anschutz Medical Campus. He is also a faculty at the Department of Surgery at the University of Colorado Denver - Anschutz Medical Campus. Dr. Zgheib earned a Doctor of Philosophy Degree in Medical Pharmacology and Toxicology with an emphasis on targeting inflammation to promote tissue repair and regeneration. Dr. Zgheib also earned a Master of Pharmacology and Cosmetology Degree, a Master of Biomedical Sciences Degree, and a Bachelor of Biochemistry Degree. Dr. Zgheib trained at the Prebys Sanford Burnham Medical Discovery Institute in Orlando, Florida where he studied regenerative medicine with an emphasis on elucidating the regulatory mechanisms of inflammation and oxidative stress in injury, and identifying potential therapeutic approaches that target these processes to promote tissue repair and healing. Dr. Zgheib is a well published author and has multiple US and International patents to his name. Dr. Zgheib received many awards including the 2016 junior faculty travel award from the Wound Healing Society, the 2018 Owen H. Wangensteen Excellence in Research Award from The American College of Surgeons, the 2019 Wound Healing Society Shark Tank Finalist, the 2021 WHF-Medline Innovation Award, and the Award for Academic Excellence and Superior Scholarship from The Honor Society of Phi Kappa Phi.